How Common is Treatment-Resistant Depression?
How common is treatment-resistant depression? Treatment-resistant depression (TRD) is a prevalent condition, affecting approximately 30% of individuals with major depressive disorder (NCBI). Despite multiple treatment attempts, including medication and therapy, these individuals do not achieve sufficient relief from their symptoms. Understanding TRD’s prevalence underscores the need for alternative treatments, such as ketamine therapy, to address this significant mental health challenge. Treatment-resistant depression (TRD) is a significant concern, affecting approximately 30% of individuals with major depressive disorder. Despite multiple treatment attempts, this prevalence highlights the challenge many face in finding effective relief from their symptoms. Addressing TRD’s impact is crucial for developing alternative therapies, such as ketamine, that offer hope for better outcomes. This article explores a common question we hear from patients interested in solutions for treatment-resistant depression: “How common is treatment-resistant depression?” What Is Treatment-Resistant Depression? Treatment-resistant depression (TRD) is a form of major depressive disorder that does not …
